Chemours (NYSE: CC) reported Q1 EPS of $0.75, $0.25 better than the analyst estimate of $0.50. Revenue for the quarter came in at $1.44 billion versus the consensus estimate of $1.32 billion.

Outlook

Vergnano commented, “Coming off our strong first quarter results, we now expect our 2017 Adjusted EBITDA to be in a range of $1.15 billion to $1.25 billion. We continue to anticipate that performance will remain strong for both Ti-Pure™ titanium dioxide and Opteon™ refrigerants. We have seen earlier than anticipated demand for some of these products, and as a result, expect first half and second half profitability to be more balanced than we saw in 2016. Guided by our transformation plan, we believe we are well positioned for the remainder of 2017, as we continue to strengthen our businesses and benefit from positive market conditions.”

For earnings history and earnings-related data on Chemours (CC) click here.